Media Coverage

March 24, 2014 Pittsburgh life sciences company developing diagnostic test for esophageal cancer

Pittsburgh life sciences company Cernostics is on the forefront of a diagnostic test for the early detection of esophageal cancer.... Read more

February 11, 2014 Cernostics receives 3 patents

Cancer diagnostics company Cernostics announced Tuesday it had received two patents in the United States and a third patent in Japan.... Read more

January 13, 2014 Cernostics taps patient registry

Cancer diagnostics company Cernostics announced collaboration with the Academic Medical Center in The Netherlands, which will give the Oakland company access to one of the world's biggest Barrett's Esophagus patient registries in the world.... Read more

January 8, 2014 Cernostics Collaborates with Academic Medical Center in The Netherlands

Cernostics, a diagnostics company focused on delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that it is collaborating with the Academic Medical Center in The Netherlands (AMC). As part of t... Read more

January 7, 2014 Cernostics, Dutch Medical Center Collaborate on Barrett’s Esophagus-related Cancer

Cernostics said on Tuesday it is collaborating with the Academic Medical Center in the Netherlands to complete validation studies of the company's test for cancer in patients with Barrett's Esophagus.... Read more

December 10, 2013 Cancer Dx Firm Cernostics Raises $1.4M

Cancer diagnostics and prognostics firm Cernostics recently announced it raised $1.4 million in a Series B financing round.... Read more

December 3, 2013 Cancer Diagnostics Company Cernostics Raises $1.4M Series B

Cernostics Inc., which is developing cancer diagnostics, has raised $1.4 million in Series B funding as it advances a test for esophageal cancer. Original investors participating in the round include Geisinger Health System, Novitas Capital an... Read more

News